• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

L-色氨酸给药对患者血浆和脑脊液中丙磺舒浓度的影响。

The effect of L-tryptophan administration on the concentration of probenecid in plasma and cerebrospinal fluid in patients.

作者信息

Dunner D L, Heiber S, Perel J M

出版信息

Psychopharmacology (Berl). 1977 Aug 16;53(3):305-8. doi: 10.1007/BF00492369.

DOI:10.1007/BF00492369
PMID:408860
Abstract

The administration of large doses of probenecid has been used to study the central nervous system metabolism of catecholamines and indoleamines in patients with affective disease. It has been reported that alterations of the binding of L-tryptophan to plasma albumin binding sites occur during probenecid administration. The present study sought to determine if the administration of large doses of L-tryptophan affected probenecid concentrations in cerebrospinal fluid and/or plasma. The data indicate that during L-tryptophan treatment, plasma probenecid concentrations are reduced but that no significant alterations in cerebrospinal fluid probenecid concentrations occur. This would suggest that the kinetics of the probenecid blockade of transport of acidic biogenic amine metabolites out of cerebrospinal fluid are not altered by L-tryptophan loading.

摘要

大剂量丙磺舒已被用于研究情感性疾病患者儿茶酚胺和吲哚胺的中枢神经系统代谢。据报道,在给予丙磺舒期间,L-色氨酸与血浆白蛋白结合位点的结合发生改变。本研究旨在确定大剂量L-色氨酸的给药是否会影响脑脊液和/或血浆中丙磺舒的浓度。数据表明,在L-色氨酸治疗期间,血浆丙磺舒浓度降低,但脑脊液中丙磺舒浓度无显著变化。这表明L-色氨酸负荷不会改变丙磺舒阻止酸性生物胺代谢产物从脑脊液中转运的动力学。

相似文献

1
The effect of L-tryptophan administration on the concentration of probenecid in plasma and cerebrospinal fluid in patients.L-色氨酸给药对患者血浆和脑脊液中丙磺舒浓度的影响。
Psychopharmacology (Berl). 1977 Aug 16;53(3):305-8. doi: 10.1007/BF00492369.
2
Determinations of 5-hydroxyindoleacetic acid and homovanillic acid in human CSF with monitoring of probenecid levels in CSF and plasma.测定人脑脊液中的5-羟吲哚乙酸和高香草酸,并监测脑脊液和血浆中的丙磺舒水平。
Psychopharmacology (Berl). 1987;92(2):144-9. doi: 10.1007/BF00177906.
3
Intravenous probenecid loading. Effects on plasma and cerebrospinal fluid probenecid levels and on monoamine metabolites in cerebrospinal fluid.静脉注射丙磺舒负荷剂量。对血浆和脑脊液中丙磺舒水平以及脑脊液中单胺代谢产物的影响。
Neurology. 1976 Oct;26(10):992-6. doi: 10.1212/wnl.26.10.992.
4
Liquid chromatographic determination of homovanillic acid, 5-hydroxyindoleacetic acid and probenecid levels in human cerebrospinal fluid during probenecid test.丙磺舒试验期间人脑脊液中高香草酸、5-羟吲哚乙酸和丙磺舒水平的液相色谱测定
Clin Chim Acta. 1984 May 16;139(1):1-12. doi: 10.1016/0009-8981(84)90186-4.
5
Steady-state levels of probenecid and their relation to acid monoamine metabolites in human cerebrospinal fluid.丙磺舒在人脑脊液中的稳态水平及其与酸性单胺代谢物的关系。
Psychopharmacologia. 1972;25(1):96-100. doi: 10.1007/BF00422621.
6
Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.情感性疾病中脑胺代谢的评估:使用丙磺舒的脑脊液研究。
Psychother Psychosom. 1974;23(1-6):142-58. doi: 10.1159/000286638.
7
3,4-Dihydroxyphenylethylamine and 5-hydroxytryptamine metabolism in the rat: acidic metabolites in cisternal cerebrospinal fluid before and after giving probenecid.大鼠体内3,4-二羟基苯乙胺和5-羟色胺的代谢:给予丙磺舒前后脑池脑脊液中的酸性代谢产物
J Neurochem. 1985 Aug;45(2):508-13. doi: 10.1111/j.1471-4159.1985.tb04017.x.
8
Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.锂:临床效应与脑脊液酸性单胺代谢产物
Commun Psychopharmacol. 1977;1(2):135-45.
9
Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration.人体血清与脑脊液中色氨酸以及脑脊液中5-羟吲哚乙酸之间的关系:肝硬化及给予丙磺舒的影响。
J Neurol Neurosurg Psychiatry. 1975 Apr;38(4):322-30. doi: 10.1136/jnnp.38.4.322.
10
Clinical pharmacokinetics of probenecid.丙磺舒的临床药代动力学。
Clin Pharmacokinet. 1981 Mar-Apr;6(2):135-51. doi: 10.2165/00003088-198106020-00004.

引用本文的文献

1
Clinical pharmacokinetics of probenecid.丙磺舒的临床药代动力学。
Clin Pharmacokinet. 1981 Mar-Apr;6(2):135-51. doi: 10.2165/00003088-198106020-00004.

本文引用的文献

1
A STUDY OF STRUCTURE--ACTIVITY RELATIONSHIPS IN REGARD TO SPECIES DIFFERENCE IN THE PHENYLBUTAZONE SERIES.关于保泰松系列物种差异的结构-活性关系研究。
Biochem Pharmacol. 1964 Sep;13:1305-17. doi: 10.1016/0006-2952(64)90231-x.
2
The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material.通过一种改进的生物材料中丙磺舒估算方法,对人体中丙磺舒的生理处置情况(包括肾脏清除率)进行了研究。
J Pharmacol Exp Ther. 1963 Jun;140:278-86.
3
Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma.
稳态动力学在5-羟色胺酸从脑到血浆转运研究中的应用。
J Pharmacol Exp Ther. 1967 Nov;158(2):214-8.
4
Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.帕金森病患者使用丙磺舒治疗后脑脊液中5-羟吲哚乙酸和高香草酸的浓度。
Nature. 1968 Aug 3;219(5153):502-3. doi: 10.1038/219502a0.
5
Rapid elevation of biogenic amine metabolites in human CSF following probenecid.丙磺舒作用后人体脑脊液中生物胺代谢物迅速升高。
Life Sci I. 1970 Dec 15;9(24):1397-408. doi: 10.1016/0024-3205(70)90134-7.
6
Identification and renal excretion of probenecid metabolites in man.人体内丙磺舒代谢产物的鉴定及经肾排泄情况
Life Sci I. 1970 Dec 1;9(23):1337-43. doi: 10.1016/0024-3205(70)90041-x.
7
5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid.丙磺舒治疗的抑郁症患者脑脊液中5-羟吲哚乙酸水平
Nature. 1970 Mar 28;225(5239):1259-60. doi: 10.1038/2251259b0.
8
Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid.脑脊液流动受限的人类腰椎脑脊液中的胺类代谢产物。
Nat New Biol. 1971 Jun 9;231(23):189-91. doi: 10.1038/newbio231189a0.
9
Origin of 5-hydroxyindoleacetic acid in the spinl fluid.脊髓液中5-羟吲哚乙酸的来源。
Science. 1971 Aug 20;173(3998):738-40. doi: 10.1126/science.173.3998.738.
10
5-Hydroxyindoleacetic acid in rat forebrain and cerebrospinal fluid following dorsal and median midbrain raphe lesions.
Brain Res. 1972 Apr 28;39(2):519-22. doi: 10.1016/0006-8993(72)90456-8.